Exhibit 99.2
Loan Agreement
between
FID Esprit AG
Rosengartenstrasse 4
CH-8608 Bubikon
Represented by Axel Kutscher (subsequently „FID Esprit”)
and
Sangui BioTech International, Inc.
Alfred-Herrhausen-Str.44
58455 Witten
Represented by Prof. Wolfgang Barnikol (President and CEO) and Dr. Joachim Fleing (Director) (Subsequently „Sangui”)
1. Background
Sangui intends to expand its cosmetics business by establishing its own internet shop and related advertizing.
FID Esprit is ready and willing to support this venture by offering a loan.
2. Amount of Loan
FID Esprit will provide €40,000.00 to Sangui in one or more installments between April 5, 2006 and May 31, 2006. The loan shall be sent by wire transfer to Sangui account No. XXXX at Stadtsparkasse Witten.
3. Interest and amortization
The loan will bear interest of 6% p.a. effective of the date of receipt of the loan.
Amortization and interest will be redeemed as of June 30, 2007 at the latest. Sangui is entitled to redeem the loan either in cash or by providing shares of common stock, valued at 50% of the average Hamburg OTC trading price of Sangui’s stock over the four weeks preceding the redemption.
4. Risk advice
Feedback has been instructed and understands that Sangui’s current business and financial situation offers raises significatn doubt that Sangui will continue as a going concern. Feedback knows that there is no assurance that the loan might not be lost althogeether eventually.
5. Severability Clause
If any term or condition of this Agreement is null and void or will become null and void during its course, then the validity and effectiveness of all other terms and conditions shall not be imparied thereby.
6. Changes of Agreement
Changes and amendments of this Agreement will not be valid unless in writing and signed by both parties.
Bubikon, April 4, 2006 Witten, July 4, 2006
/s/ Axel Kutscher /s/ Prof. Wolfgang Barnikol
________________________ ________________________
Axel Kutscher Prof. Wolfgang Barnikol
FID Esprit AG Sangui BioTech International, Inc.
/s/ Dr. Joachim Fleing
________________________
Dr. Joachim Fleing
Sangui BioTech International, Inc.